Abstract
Bioactivity-guided fractionation of MeOH extract from leaves of Alchornea glandulosa Poepp. (Euphorbiaceae) afforded a new guanidine alkaloid named alchornedine. Its structure, which displayed a very rare ring system, was elucidated based on NMR, IR and MS spectral analysis. Alchornedine displayed an antiprotozoal activity against Trypanosoma cruzi (Y strain). By using the MTT assay, the trypomastigotes showed an IC50 value of 92.54 µg/mL (442.8µM), a similar effectiveness to the standard drug benznidazole. Alchornedine showed a promising activity against the intracellular amastigotes, with an IC50 value of 27.17 µg/mL (129.1µM). Considering benznidazole as standard drug, this guanidine alkaloid was approximately 3-fold more effective against the intracellular form of T. cruzi. The mammalian cytotoxicity of alchornedine was verified against NCTC cells and demonstrated an IC50 of 49.62 µg/mL (237.4µM), but the compound demonstrated a selective elimination of parasites inside macrophages, without affecting the morphology of host cells. Alchornedine was effective against both clinical forms of T. cruzi and could be used as a scaffold for future drug design studies against American Trypanosomiais.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
